MannKind Market Cap

MannKind has a market cap or net worth of $805.68 million as of March 9, 2026. Its market cap has decreased by -48.38% in one year.

Market Cap

805.68M

Enterprise Value

1.11B

1-Year Change

-48.38%

Ranking

#2681

Market Cap Chart

Since July 28, 2004, MannKind's market cap has increased from $445.50M to $805.68M, an increase of 80.85%. That is a compound annual growth rate of 2.78%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	804.10M	-53.82%
Dec 31, 2025	1.74B	-1.82%
Dec 31, 2024	1.77B	80.71%
Dec 29, 2023	981.30M	-29.25%
Dec 30, 2022	1.39B	26.32%
Dec 31, 2021	1.10B	50.82%
Dec 31, 2020	728.00M	173.38%
Dec 31, 2019	266.30M	57.39%
Dec 31, 2018	169.20M	-37.75%
Dec 29, 2017	271.80M	-10.74%
Dec 30, 2016	304.50M	-48.72%
Dec 31, 2015	593.80M	-71.93%
Dec 31, 2014	2.12B	13.87%
Dec 31, 2013	1.86B	227.29%
Dec 31, 2012	567.70M	72.92%
Dec 30, 2011	328.30M	-67.35%
Dec 31, 2010	1.01B	1.76%
Dec 31, 2009	988.20M	183.23%
Dec 31, 2008	348.90M	-56.57%
Dec 31, 2007	803.30M	-2.49%
Dec 29, 2006	823.80M	45.65%
Dec 30, 2005	565.60M	9.46%
Dec 31, 2004	516.70M	15.98%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sana Biotechnology	840.63M
Evommune	835.39M
BridgeBio Oncology Therapeutics	833.48M
Xencor	830.19M
KalVista Pharmaceuticals	820.37M
Omeros	818.19M
MapLight Therapeutics	807.80M
CytomX Therapeutics	792.96M

Market Cap Rankings